Concerning the treatments for cardiovascular diseases, no significant differences were found among stroke risk groups in the proportion of use of several drugs like antiarrhythmics, antianginals, angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor antagonists, alpha and beta blockers, calcium channel blockers, potassium-sparing and thiazide diuretics, anticoagulants, and venotropics (Table 3). This evidence concerns the gene ACE and Stroke.